Student electives for Gina Hadley, Clare Webb, Zoeb Jiwaji, Emily Parker and Jonarthan Thevanayagam. (360G-Wellcome-083630_Z_07_Z)
Malaria is one of the deadliest infectious parasitic diseases. Combination therapy, which has already been introduced in Kenya may not address the problem of the ability of the parasite to quickly select for resistance against antimalarial drugs, due to the detrimental effect of disparate pharmacokinetic profiles of drugs used. Strategies have to be devised to tackle the drug resistance. One such strategy is to predict and monitor the emergence and the spread of drug resistance parasite before drug resistance become s a problem. As Co-artem® has already been introduced in Kenya, the information that this project will provide is vital.
£5,600 18 Jul 2007